122882
2-氨基-4-氯-6-甲基嘧啶
97%
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C5H6ClN3
化学文摘社编号:
分子量:
143.57
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
227-018-3
Beilstein/REAXYS Number:
114297
MDL number:
Assay:
97%
Form:
solid
InChI key
NPTGVVKPLWFPPX-UHFFFAOYSA-N
InChI
1S/C5H6ClN3/c1-3-2-4(6)9-5(7)8-3/h2H,1H3,(H2,7,8,9)
SMILES string
Cc1cc(Cl)nc(N)n1
assay
97%
form
solid
Quality Level
solubility
acetic acid: soluble 50 mg/mL, clear, colorless to faintly yellow
functional group
chloro
General description
2-Amino-4-chloro-6-methylpyrimidine is a nitification inhibitor.
Application
2-Amino-4-chloro-6-methylpyrimidine was used to study the influence of chlorine substitution in pyrimidine ring on proton donor ability of amino group in 2-aminopyrimidine.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Effects of nitrification inhibitors on denitrification of nitrate in soil.
Bremner JM andYeomans JC.
Biology and Fertility of Soils, 2(4), 173-179 (1986)
Influence of chlorine-substitution in pyrimidine ring on proton donor ability in H-bond and parameters of amino group of 2-amino pyrimidine.
Borisenko VE, et al.
Vibrational Spectroscopy, 37(1), 97-109 (2005)
T Jayavarthanan et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 97, 811-824 (2012-08-21)
The solid phase FTIR and FT-Raman spectra of 2-amino-4-chloro-6-methylpyrimidine (2A4Cl6MP) have been recorded in the regions 400-4000 and 50-4,000 cm(-1), respectively. The spectra have been interpreted interms of fundamentals modes, combination and overtone bands. The structure of the molecule has
J A Hutter et al.
Biochemistry, 26(7), 1969-1973 (1987-04-07)
Thiaminase I from Bacillus thiaminolyticus strain Matsukawa et Misawa is completely and irreversibly inhibited by treatment with 4-amino-6-chloro-2-methylpyrimidine. Inhibition is a time-dependent first-order process, exhibiting a half-time of 4 h at an inhibitor concentration of 5 mM. A specific active-site-directed
Christer B Aakeröy et al.
Pharmaceutics, 3(3), 601-614 (2011-01-01)
In the pharmaceutical industry, co-crystals are becoming increasingly valuable as crystalline solids that can offer altered/improved physical properties of an active pharmaceutical ingredient (API) without changing its chemical identity or biological activity. In order to identify new solid forms of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持